An analyst from the biotech consulting group Biotechvalley Insights believes after bitcoin lost 53% from the crypto assetâ€™s all-time high, â€œthe party is clearly over.â€ The biotech consulting group analyst thinks crypto investors will witness a slow â€œgrind down the slope of hope with a periodic dead cat bounceâ€ and expects prices to drop to $15,000 in the next few weeks.
Analyst Says to Drop Bitcoin and Never Look Back
According to an analyst from Biotechvalley Insights, crypto investors should sell bitcoin and â€œdo not look back.â€ The analyst said that he had warned investors in a previous article, before bitcoin (BTC) collapsed from a high of $64,895 to $30,066 losing more than 50% in value. The biotech consulting group investor stresses that people â€œshould consider liquidating anything related to bitcoin or short it.â€
â€œ[The] recent collapse proves that Bitcoin isnâ€™t a safe haven, store of value, or a hedge against inflation/market correction, but a speculative token that can go down 50% in a week,â€ the article published on Tuesday notes. â€œBitcoin has exhausted its exotic catalysts and is under coordinated regulatory attack by governments around the world. At this point, I donâ€™t think there is anything that can save it from collapsing more,â€ the analystâ€™s report adds.
â€œEthereum took out its May 19th low of $1,850. Bitcoin is less than $2K away from taking out itâ€™s May 19th low too. On May 10th the total market capitalization of 10,000 crypto currencies hit a high of $2.485 trillion. It took less than two weeks to fall below $1.3 trillion,â€ Schiff said.
Biotechvalley Analyst Plans to Short Bitcoin All the Way Down to a $15K Target
The Biotechvalley Insightsâ€™ analyst believes that bitcoinâ€™s downward spiral will take longer than most expect. The analystâ€™s target price is $15,000â€“$16,000 per BTC, but further says â€œthe million-dollar question at this point would be, are we out of the woods?â€ The biotech consulting group researcherâ€™s study emphasizes:
Bitcoin (BTC) and a myriad of other cryptocurrencies have been facing fierce scrutiny over environmental concerns, and governments are cracking down with excessive regulations. The biotech analyst says those are definitely issues, but cryptocurrencies also â€œhave an extreme level of leverage.â€
â€œAny unexpected price movement downward can lead to rapid liquidations as many investors canâ€™t meet the margin requirement,â€ the report notes. â€œAdding to that, it is no secret that bitcoin whales profit from this excessive leverage by manipulating the market and causing unexpected volatility to liquidate retail investorsâ€™ positions.â€
The analystâ€™s game plan is to short bitcoin (BTC) â€œuntil US$31k and liquidate 30-50% of the position to cover the cost base and continuously short with the houseâ€™s money.â€ The researcher thinks there will be key resistance in this range but after it breaks down resistance around â€œ$19-20kâ€ is expected.
What do you think about the Biotechvalley Insights analyst and the target of $15,000â€“$16,000 per bitcoin? Let us know what you think about this subject in the comments section below.
Disclaimer: This article is for informational purposes only. It is not a direct offer or solicitation of an offer to buy or sell, or a recommendation or endorsement of any products, services, or companies. Bitcoin.com does not provide investment, tax, legal, or accounting advice. Neither the company nor the author is responsible, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with the use of or reliance on any content, goods or services mentioned in this article.